American International Group’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-15,246
| Closed | -$107K | – | 1092 |
|
2024
Q1 | $107K | Buy |
15,246
+86
| +0.6% | +$606 | ﹤0.01% | 2473 |
|
2023
Q4 | $85.7K | Sell |
15,160
-61
| -0.4% | -$345 | ﹤0.01% | 2643 |
|
2023
Q3 | $72.9K | Buy |
15,221
+541
| +4% | +$2.59K | ﹤0.01% | 2683 |
|
2023
Q2 | $101K | Buy |
14,680
+325
| +2% | +$2.23K | ﹤0.01% | 2571 |
|
2023
Q1 | $112K | Buy |
14,355
+285
| +2% | +$2.22K | ﹤0.01% | 2405 |
|
2022
Q4 | $107K | Buy |
14,070
+458
| +3% | +$3.49K | ﹤0.01% | 2470 |
|
2022
Q3 | $111K | Buy |
13,612
+192
| +1% | +$1.57K | ﹤0.01% | 2492 |
|
2022
Q2 | $130K | Sell |
13,420
-922
| -6% | -$8.93K | ﹤0.01% | 2438 |
|
2022
Q1 | $201K | Buy |
14,342
+7,932
| +124% | +$111K | ﹤0.01% | 2232 |
|
2021
Q4 | $131K | Buy |
6,410
+77
| +1% | +$1.57K | ﹤0.01% | 2605 |
|
2021
Q3 | $141K | Buy |
+6,333
| New | +$141K | ﹤0.01% | 2631 |
|